8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jan 13, 2025 · 1y ago · Accession 0001517022-25-000004
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Jan 13, 2025
- Report date
- Jan 13, 2025
- Document
- akba-20250113.htm
- Size
- 3.8 MB